Cargando…

Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and outcome depends on cell type, secretory product, his...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kidd, Mark, Modlin, Irvin M., Bodei, Lisa, Drozdov, Ignat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301133/ https://www.ncbi.nlm.nih.gov/pubmed/28210673 http://dx.doi.org/10.1016/j.jcmgh.2014.12.008

Ejemplares similares

Blood transcript analysis and metastatic recurrent small bowel carcinoid management
por: Modlin, Irvin M, et al.
Publicado: (2014)

Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms()
por: Schimmack, Simon, et al.
Publicado: (2016)

The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
por: Modlin, Irvin M., et al.
Publicado: (2013)

A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
por: Modlin, Irvin M, et al.
Publicado: (2014)

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
por: Malczewska, Anna, et al.
Publicado: (2019)

Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors
por: Kidd, Mark, et al.
Publicado: (2014)

Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
por: Kidd, Mark, et al.
Publicado: (2019)

A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
por: Kidd, Mark, et al.
Publicado: (2017)

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
por: Oberg, Kjell, et al.
Publicado: (2016)

Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia
por: Drozdov, Ignat, et al.
Publicado: (2011)

The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
por: Venizelos, Andreas, et al.
Publicado: (2021)

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Mafficini, Andrea, et al.
Publicado: (2019)

An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
por: Fang, Jiayun M, et al.
Publicado: (2022)

Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms
por: Ramachandran, Anupama, et al.
Publicado: (2022)

Discussion: Enterochromaffin-Like Cell Pathobiology
por: Modlin, Irvin M.
Publicado: (1992)

Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
por: Kawasaki, Kenta, et al.
Publicado: (2018)

Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot
por: Fernandez, Cornelius J, et al.
Publicado: (2021)

Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
por: Giovinazzo, Francesco, et al.
Publicado: (2013)

Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms
por: Kikut, Justyna, et al.
Publicado: (2020)

Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms
por: Mahečić, Davorka Herman, et al.
Publicado: (2020)

Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland
por: Alwan, Heba, et al.
Publicado: (2020)

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Takayanagi, Daisuke, et al.
Publicado: (2022)

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
por: Yin, Feng, et al.
Publicado: (2022)

Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
por: Dai, Meng, et al.
Publicado: (2022)

Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Budek, Marlena, et al.
Publicado: (2022)

Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Alexandraki, Krystallenia I., et al.
Publicado: (2017)

Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
por: Lopes, José Manuel
Publicado: (2017)

SUN-302 Incidence Trends in Lung and Gastroenteropancreatic Neuroendocrine Neoplasms
por: Alwan, Heba, et al.
Publicado: (2020)

Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms
por: Stankiewicz, Rafał, et al.
Publicado: (2022)

The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Xu, Shuaishuai, et al.
Publicado: (2022)

Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
por: Koffas, Apostolos, et al.
Publicado: (2023)

Site‐specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany
por: Grundmann, Nina, et al.
Publicado: (2023)

Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms
por: Yao, Hailing, et al.
Publicado: (2023)

Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria
por: Sandvik, O. M., et al.
Publicado: (2015)

Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms
por: Fang, Cheng, et al.
Publicado: (2017)

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
por: Wang, Yuhong, et al.
Publicado: (2018)

Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms
por: Spychalski, Michał, et al.
Publicado: (2016)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
por: Shi, Huiying, et al.
Publicado: (2020)

Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5tvm23738mkbv9ocjpjtjsai6o